Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2007

Nov 14, 2007

34117_dirs_2007-11-14_bba6b711-0a97-40b1-8081-25bbd0531328.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2007-11-12

Reporting Person: DISANTO FRANK J (Director, President)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-11-12 Employee Stock Option $1.17 A 300000 Acquired 2017-11-11 Common Stock (300000) Direct

Footnotes

F1: Right-To-Buy, pursuant to the Copytele, Inc. 2003 Share Incentive Plan.